BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26499424)

  • 1. Management of women at high risk of hereditary breast cancer in the Veneto Regional Program for Prevention.
    Del Sole A; Cinquetti S; Fedato C; Montagna M; Russo F; Sbrogiò LG; Zorzi M
    Epidemiol Prev; 2015; 39(4 Suppl 1):99-101. PubMed ID: 26499424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic testing by cancer site: ovary.
    Weissman SM; Weiss SM; Newlin AC
    Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
    Drohan B; Roche CA; Cusack JC; Hughes KS
    Ann Surg Oncol; 2012 Jun; 19(6):1732-7. PubMed ID: 22427173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor risk consultation for predisposed women from high risk cancer families].
    Beckmann MW; Niederacher D; Bodden-Heidrich R; Goecke TO; Kuschel B; Achnoula M; Aba F; Schnürch HG; Bender HG
    Praxis (Bern 1994); 1998 Apr; 87(15):511-5. PubMed ID: 9608246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic surgery in common hereditary cancer syndromes].
    Noguès C; Mouret-Fourme E
    Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary breast and ovarian cancer syndrome: should we test adolescents?
    Seeber B; Driscoll DA
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):161-7. PubMed ID: 15125901
    [No Abstract]   [Full Text] [Related]  

  • 8. Audit of women attending the Aberdeen Genetic Clinic with a family history of breast cancer who subsequently develop cancer.
    Gregory H; Gibbons B; Haites N
    Dis Markers; 1999 Oct; 15(1-3):201-3. PubMed ID: 10595279
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
    Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
    Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes].
    Narod SA; Rodríguez AA
    Salud Publica Mex; 2011; 53(5):420-9. PubMed ID: 22218796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary ovarian cancer.
    Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing.
    Foulkes WD; Narod SA
    Clin Invest Med; 1995 Dec; 18(6):473-83. PubMed ID: 8714791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population.
    Dominguez FJ; Jones JL; Zabicki K; Smith BL; Gadd MA; Specht M; Kopans DB; Moore RH; Michaelson JS; Hughes KS
    Cancer; 2005 Nov; 104(9):1849-53. PubMed ID: 16136597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD].
    Schmutzler R; Schlegelberger B; Meindl A; Gerber WD; Kiechle M;
    Zentralbl Gynakol; 2003 Dec; 125(12):494-506. PubMed ID: 14755360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screening].
    Lassetn C; Bonadona V
    Bull Cancer; 2001 Jul; 88(7):677-86. PubMed ID: 11495821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.